Reply to Letter to the Editor about "Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis" by Qiang et al

World J Urol. 2024 Nov 4;42(1):621. doi: 10.1007/s00345-024-05304-7.

Andreas Karlsson Rosenblad^{1

2

3

4}, Bassam Mazin Hashim⁵, Per Lindblad⁶, Börje Ljungberg⁷; National Swedish Kidney Cancer Register Steering Committee

National Swedish Kidney Cancer Register Steering Committee:
Anca Dragomir, Anders Kjellman, Bianca Scholtz, Britt-Inger Dahlin, Emma Mangelus, Emma Ulvskog, Linn Pettersson, Magnus Lindskog, Marcus Thomasson, Martin Johansson, Mikael Hellström, Per Skoglund, Pernilla Sundqvist, Sigrid Isaksson, Stephanie Bonn, Susanna Holst, Sven Lundstam, Ulrika Harmenberg

¹ Regional Cancer Centre Stockholm-Gotland, Region Stockholm, Stockholm, Sweden.
² Department of Statistics, Uppsala University, Uppsala, Sweden.
³ Department of Medical Sciences, Division of Clinical Diabetology and Metabolism, Uppsala University, Uppsala, Sweden.
⁴ Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Surgical Sciences, Center for Clinical Research, County of Västmanland, Uppsala University, Uppsala, Sweden.
⁶ Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
⁷ Department of Diagnostics and Intervention, Urology and Andrology, Umeå University, 901 85, Umeå, Sweden. borje.ljungberg@umu.se.

No abstract available

Publication types